Robert T. Dorr

7.6k total citations · 1 hit paper
157 papers, 6.1k citations indexed

About

Robert T. Dorr is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Robert T. Dorr has authored 157 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 42 papers in Oncology and 37 papers in Organic Chemistry. Recurrent topics in Robert T. Dorr's work include Cancer therapeutics and mechanisms (40 papers), Cancer Treatment and Pharmacology (18 papers) and Synthesis and Biological Evaluation (13 papers). Robert T. Dorr is often cited by papers focused on Cancer therapeutics and mechanisms (40 papers), Cancer Treatment and Pharmacology (18 papers) and Synthesis and Biological Evaluation (13 papers). Robert T. Dorr collaborates with scholars based in United States, New Zealand and Japan. Robert T. Dorr's co-authors include David S. Alberts, William L. Fritz, Mac E. Hadley, Terry H. Landowski, H.‐H. Sherry Chow, James D. Liddil, William A. Remers, Victor J. Hruby, Barbara N. Timmermann and Kateřina Dvořáková and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Robert T. Dorr

157 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

2003 568 citations H.‐H. Sherry Chow, Robert T. Dorr et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert T. Dorr United States	43	2.4k	1.5k	996	717	502	157	6.1k
Robert W. Egan United States	54	3.9k 1.6×	693 0.5×	535 0.5×	354 0.5×	213 0.4×	183	10.9k
Kazuo Umezawa Japan	51	5.3k 2.2×	2.1k 1.4×	1.1k 1.1×	702 1.0×	223 0.4×	425	11.0k
Yong‐Yeon Cho South Korea	54	5.1k 2.1×	1.5k 1.0×	358 0.4×	657 0.9×	460 0.9×	268	8.6k
Ikuo Saiki Japan	58	5.5k 2.3×	3.4k 2.3×	821 0.8×	425 0.6×	147 0.3×	333	12.1k
Dieter Steinhilber Germany	49	3.9k 1.6×	984 0.7×	1.6k 1.6×	573 0.8×	104 0.2×	296	9.6k
Ying Huang United States	45	4.6k 1.9×	1.5k 1.1×	683 0.7×	422 0.6×	117 0.2×	195	8.3k
Sunil K. Manna India	45	2.6k 1.1×	884 0.6×	437 0.4×	331 0.5×	85 0.2×	105	6.8k
Kenneth K. Chan United States	47	5.0k 2.1×	1.3k 0.9×	446 0.4×	500 0.7×	154 0.3×	172	8.1k
Carole Nicco France	37	2.2k 0.9×	612 0.4×	316 0.3×	717 1.0×	301 0.6×	107	5.2k
Umberto Dianzani Italy	66	5.9k 2.4×	2.0k 1.4×	1.2k 1.2×	1.6k 2.2×	149 0.3×	462	16.6k

Countries citing papers authored by Robert T. Dorr

Since Specialization

Citations

This map shows the geographic impact of Robert T. Dorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Dorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Dorr more than expected).

Fields of papers citing papers by Robert T. Dorr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Dorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Dorr. The network helps show where Robert T. Dorr may publish in the future.

Co-authorship network of co-authors of Robert T. Dorr

This figure shows the co-authorship network connecting the top 25 collaborators of Robert T. Dorr. A scholar is included among the top collaborators of Robert T. Dorr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert T. Dorr. Robert T. Dorr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Samulitis, Betty K., Anne E. Cress, Hitendra Patel, et al.. (2014). Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. Cancer Biology & Therapy. 16(1). 43–51. 54 indexed citations

Jagadish, Bhumasamudram, et al.. (2012). Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of Gadolinium. Translational Oncology. 5(3). 190–199. 8 indexed citations

Henderson, Meredith C., Hong Wang, Haiyong Han, et al.. (2009). UA62784, a novel inhibitor of centromere protein E kinesin-like protein. Molecular Cancer Therapeutics. 8(1). 36–44. 42 indexed citations

Bai, Xue‐Feng, Jianhua Huang, Denise I. Campagnolo, et al.. (2007). Therapeutic Effect of Anthracene-Based Anticancer Agent Ethonafide in an Animal Model of Multiple Sclerosis. The Journal of Immunology. 179(11). 7415–7423. 18 indexed citations

Pourpak, Alan, Ross O. Meyers, Betty K. Samulitis, et al.. (2006). Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice. Anti-Cancer Drugs. 17(10). 1179–1184. 11 indexed citations

Fukushima, Shoji, et al.. (2005). Imexon and gemcitabine are synergistic against human pancreatic cancer cells in vitro and in vivo. Cancer Research. 65. 1385–1385. 1 indexed citations

Chvapil, Miloš & Robert T. Dorr. (2005). Single intratumoral injection of long-acting benzyl ester of D-penicillamine inhibits the growth of melanoma tumor in mice. Anti-Cancer Drugs. 16(7). 757–762. 4 indexed citations

Samulitis, Betty K., Terry H. Landowski, & Robert T. Dorr. (2005). Correlates of imexon sensitivity in human multiple myeloma cell lines. Leukemia & lymphoma. 47(1). 97–109. 12 indexed citations

Lambert, Joshua D., Ross O. Meyers, Barbara N. Timmermann, & Robert T. Dorr. (2001). tetra-O-Methylnordihydroguaiaretic acid inhibits melanoma in vivo. Cancer Letters. 171(1). 47–56. 44 indexed citations

10.

Dvořáková, Kateřina, Robert T. Dorr, Alfred Gallegos, Thomas D. McClure, & Garth Powis. (1997). Pharmacokinetic studies of the herbicide and antitumor compound oryzalin in mice. Journal of Chromatography B Biomedical Sciences and Applications. 696(2). 275–281. 7 indexed citations

11.

Gensler, Helen L., Barbara N. Timmermann, Susanne Valcic, et al.. (1996). Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Nutrition and Cancer. 26(3). 325–335. 105 indexed citations

12.

Dorr, Robert T., et al.. (1995). Antidote studies of vinorelbine-induced skin ulceration in the mouse. Cancer Chemotherapy and Pharmacology. 36(4). 290–292. 4 indexed citations

13.

Dorr, Robert T., et al.. (1995). Amino-Substituted 2-[2-(Dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. Synthesis, Antitumor Activity, and Quantitative Structure-Activity Relationship. Journal of Medicinal Chemistry. 38(6). 983–993. 35 indexed citations

14.

Johnson, Paula D., Brenda V. Dawson, Robert T. Dorr, et al.. (1994). Coat color darkening in a dog in response to a potent melanotropic peptide. American Journal of Veterinary Research. 55(11). 1593–1596. 5 indexed citations

15.

Dorr, Robert T.. (1994). Pharmacology and Toxicology of Cremophor EL Diluent. Annals of Pharmacotherapy. 28(5_suppl). S11–S14. 204 indexed citations

16.

Meyskens, F. L., Earl A. Surwit, Thomas E. Moon, et al.. (1994). Enhancement of Regression of Cervical Intraepithelial Neoplasia II (Moderate Dysplasia) With Topically Applied All- trans -Retinoic Acid: a Randomized Trial. JNCI Journal of the National Cancer Institute. 86(7). 539–543. 199 indexed citations

17.

Islam, Imadul, Edward B. Skibo, Robert T. Dorr, & David S. Alberts. (1991). Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents. Journal of Medicinal Chemistry. 34(10). 2954–2961. 61 indexed citations

18.

Bellamy, William, Robert T. Dorr, William S. Dalton, & David S. Alberts. (1988). Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.. PubMed. 48(22). 6360–4. 25 indexed citations

19.

Dorr, Robert T., Brenda V. Dawson, Fahad Al‐Obeidi, et al.. (1988). Toxicologic studies of a superpotent α-melanotropin, [Nle4, D-Phe7]α-MSH. Investigational New Drugs. 6(4). 251–258. 21 indexed citations

20.

Dorr, Robert T., et al.. (1986). Controlled Studies of a New Microprocessor-Based Portable Infusion Pump. PubMed. 3(2). 139–146. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact